NASDAQ | ETF
The fund invests at least 80% of its total assets in the securities of the underlying index.
The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.86% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 5.38% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 4.62% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 4.49% |
| QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 4.45% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.37% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 4.24% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.14% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 4.01% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.01% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.00% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.97% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.46% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 3.40% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.26% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 3.16% |
| RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 2.98% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 2.87% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.56% |
| 1548 | Genscript Biotech Corp | Healthcare | Biotechnology | 2.55% |